Developing 'integrative' zebrafish models of behavioral and metabolic disorders

Behavioural Brain Research

Volumn 256, Issue , 2013, Pages 172-187

  Nguyen, Michael ^a,b   Yang, Ester ^b,c   Neelkantan, Nikhil ^d   Mikhaylova, Alina ^d   Arnold, Raymond ^d   Poudel, Manoj K ^d   Stewart, Adam Michael ^e,f   Kalueff, Allan V ^f  

^a University of Virginia   (United States)

^b THOMAS JEFFERSON HIGH SCHOOL FOR SCIENCE AND TECHNOLOGY   (United States)

^c MOUNT HOLYOKE COLLEGE   (United States)

^d International American University College of Medicine   (Saint Lucia)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f The International Zebrafish Neuroscience Research Consortium (ZNRC)   (United States)

Author keywords

Comorbidity; Metabolic disorders; Neurobehavioral disorders; Obesity; Stress; Zebrafish models

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACYLTRANSFERASE; AGOUTI RELATED PROTEIN; ANANDAMIDE; ANTIOBESITY AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; BUTENOLIDE; CARBOXYPEPTIDASE H; CATECHOL DERIVATIVE; CCAAT ENHANCER BINDING PROTEIN; CORTICOTROPIN RELEASING FACTOR; FLUOXETINE; GHRELIN; GHRELIN 2; GHRELIN O ACYLTRANSFERASE; GONADORELIN; GREEN TEA EXTRACT; GROWTH HORMONE; HYDROCORTISONE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; LEPTIN; MELANOCORTIN; NEUROPEPTIDE Y; OREXIN A; PROOPIOMELANOCORTIN; RIMONABANT; SEROTONIN TRANSPORTER; STEROL REGULATORY ELEMENT BINDING PROTEIN; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; ANXIETY DISORDER; BEHAVIOR DISORDER; BODY MASS; CARBOHYDRATE METABOLISM; COMORBIDITY; DEPRESSION; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE MODEL; DNA MICROARRAY; DRUG TARGETING; ENERGY EXPENDITURE; FEEDING BEHAVIOR; GENE; GENE CONTROL; GENE DUPLICATION; GENE EXPRESSION; GENE FUNCTION; GENETIC CONSERVATION; GHRELIN GENE; HEREDITY; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KCTD13 GENE; MENTAL STRESS; METABOLOMICS; MICROFLORA; MOLECULAR EVOLUTION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; POMC GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SEX DIFFERENCE; SPECIES DIFFERENCE; TRANQUILIZING ACTIVITY; WHOLE BODY SCINTISCANNING; ZEBRA FISH; ANIMAL; MENTAL DISEASE; METABOLIC DISORDER; PHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MENTAL DISORDERS; METABOLIC DISEASES; OBESITY; STRESS, PSYCHOLOGICAL; ZEBRAFISH;

EID: 84883262851     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.08.012     Document Type: Review

References (298)

1. Adamus-Leach H.J., Wilson P.L., O'Connor D.P., Rhode P.C., Mama S.K., Lee R.E. Depression, stress and body fat are associated with binge eating in a community sample of African American and Hispanic women. Eating and Weight Disorders: EWD 2013, 18:221-227.
2. Wang Q., Verweij E.W., Krugers H.J., Joels M., Swaab D.F., Lucassen P.J. Distribution of the glucocorticoid receptor in the human amygdala; changes in mood disorder patients. Brain Structure & function 2013, 10.1007/s00429-013-0589-4.
3. Hawkins M.A.W., Stewart J.C. Do negative emotional factors have independent associations with excess adiposity. Journal of Psychosomatic Research 2012, 73:243-250.
4. van Reedt Dortland A.K.B., Giltay E.J., van Veen T., Zitman F.G., Penninx B.W.J.H. Longitudinal relationship of depressive and anxiety symptoms with dyslipidemia and abdominal obesity. Psychosomatic Medicine 2013, 75:83-89.
5. Lopresti A.L., Drummond P.D. Obesity and psychiatric disorders: commonalities in dysregulated biological pathways and their implications for treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2013, 45C:92-99.
6. Coccurello R., D'Amato F.R., Moles A. Chronic social stress, hedonism and vulnerability to obesity: lessons from rodents. Neuroscience & Biobehavioral Reviews 2009, 33:537-550.
7. Fernando H.A., Chin H.F., Ton S.H., Abdul Kadir K. Stress and its effects on glucose metabolism and 11beta-HSD activities in rats fed on a combination of high-fat and high-sucrose diet with glycyrrhizic acid. Journal of Diabetes Research 2013, 2013:190395.
8. Kas M.J., Fernandes C., Schalkwyk L.C., Collier D.A. Genetics of behavioural domains across the neuropsychiatric spectrum; of mice and men. Molecular Psychiatry 2007, 12:324-330.
9. Kalueff A.V., Wheaton M., Murphy D.L. What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behavioural Brain Research 2007, 179:1-18.
10. Kalueff A.V., Schmidt M.V. Novel experimental models and paradigms for neuropsychiatric disorders: editorial. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011, 35:1355-1356.
11. Stewart A., Gaikwad S., Kyzar E., Green J., Roth A., Kalueff A.V. Modeling anxiety using adult zebrafish: a conceptual review. Neuropharmacology 2012, 62:135-143.
12. Stewart A., Kadri F., DiLeo J., Chung K., Cachat J., Goodspeed J., et al. The developing utility of zebrafish in modeling neurobehavioral disorders. International Society for Comparative Psychology 2010, 23:104-121.
13. Lieschke G.J., Currie P.D. Animal models of human disease: zebrafish swim into view. Nature Reviews Genetics 2007, 8:353-367.
14. Kinkel M.D., Prince V.E. On the diabetic menu: zebrafish as a model for pancreas development and function. Bioessays 2009, 31:139-152.
15. Asaoka Y., Terai S., Sakaida I., Nishina H. The expanding role of fish models in understandingnon-alcoholic fatty liver disease. Disease Models & Mechanisms 2013, 6(4):905-914.
16. Briggs J.P. The zebrafish: a new model organism for integrative physiology. American Journal of Physiology Regulatory, Integrative and Comparative Physiology 2002, 282:R3-R9.
17. Holtta-Vuori M., Salo V.T., Nyberg L., Brackmann C., Enejder A., Panula P., et al. Zebrafish: gaining popularity in lipid research. The Biochemical Journal 2010, 429:235-242.
18. Anderson J.L., Carten J.D., Farber S.A. Zebrafish lipid metabolism: from mediating early patterning to the metabolism of dietary fat and cholesterol. Methods in Cell Biology 2011, 101:111-141.
19. Song Y., Cone R.D. Creation of a genetic model of obesity in a teleost. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2007, 21:2042-2049.
20. Tingaud-Sequeira A., Ouadah N., Babin P.J. Zebrafish obesogenic test: a tool for screening molecules that target adiposity. Journal of Lipid Research 2011, 52:1765-1772.
21. Blaser R., Gerlai R. Behavioral phenotyping in zebrafish: comparison of three behavioral quantification methods. Behavior Research Methods 2006, 38:456-469.
22. Blaser R.E., Rosemberg D.B. Measures of anxiety in zebrafish (Danio rerio): dissociation of black/white preference and novel tank test. PLoS ONE 2012, 7:e36931.
23. Cachat J., Canavello P., Elegante M., Bartels B., Hart P., Bergner C., et al. Modeling withdrawal syndrome in zebrafish. Behavioural Brain Research 2010, 208:371-376.
24. Wong K., Elegante M., Bartels B., Elkhayat S., Tien D., Roy S., et al. Analyzing habituation responses to novelty in zebrafish (Danio rerio). Behavioural Brain Research 2010, 208:450-457.
25. Craig P.M., Moon T.W. Fasted zebrafish mimic genetic and physiological responses in mammals: a model for obesity and diabetes. Zebrafish 2011, 8:109-117.
26. Driever W., Stemple D., Schier A., Solnica-Krezel L. Zebrafish: genetic tools for studying vertebrate development. Trends in Genetics 1994, 10:152-159.
27. Schlegel A., Stainier D.Y. Lessons from "lower" organisms: what worms, flies, and zebrafish can teach us about human energy metabolism. PLoS Genetics 2007, 3:e199.
28. Shin J.T., Fishman M.C. From zebrafish to human: modular medical models. Annual Review of Genomics and Human Genetics 2002, 3:311-340.
29. Alsop D., Vijayan M.M. Development of the corticosteroid stress axis and receptor expression in zebrafish. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2008, 294:R711-R719.
30. Cerda-Reverter J.M., Agulleiro M.J., Guillot R., Sanchez E., Ceinos R., Rotllant J. Fish melanocortin system. European Journal of Pharmacology 2011, 660:53-60.
31. Enjin A., Suh G.S. Neural mechanisms of alarm pheromone signaling. Molecules and Cells 2013, 35:177-181.
32. Levin E.D., Bencan Z., Cerutti D.T. Anxiolytic effects of nicotine in zebrafish. Physiology & Behavior 2007, 90:54-58.
33. Egan R.J., Bergner C.L., Hart P.C., Cachat J.M., Canavello P.R., Elegante M.F., et al. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behavioural Brain Research 2009, 205:38-44.
34. Gaikwad S., Stewart A., Hart P., Wong K., Piet V., Cachat J., et al. Acute stress disrupts performance of zebrafish in the cued and spatial memory tests: the utility of fish models to study stress-memory interplay. Behavioural Processes 2011, 87:224-230.
35. Speedie N., Gerlai R. Alarm substance induced behavioral responses in zebrafish (Danio rerio). Behavioural Brain Research 2008, 188:168-177.
36. LaPorte J.L., Egan R.J., Hart P.C., Bergner C.L., Cachat J.M., Canavello P.R., et al. Quinon proficit, deficit: experimental models for 'integrative' research of affective disorders. Journal of Affective Disorders 2010, 121:1-9.
37. Lara D.R., Pinto O., Akiskal K., Akiskal H.S. Toward an integrative model of the spectrum of mood, behavioral and personality disorders based on fear and anger traits: I. Clinical implications. Journal of Affective Disorders 2006, 94:67-87.
38. Kalueff A.V., Ren-Patterson R.F., LaPorte J.L., Murphy D.L. Domain interplay concept in animal models of neuropsychiatric disorders: a new strategy for high-throughput neurophenotyping research. Behavioural Brain Research 2008, 188:243-249.
39. Lob-Corzilius T. Overweight and obesity in childhood - a special challenge for public health. International Journal of Hygiene and Environmental Health 2007, 210:585-589.
40. Sørensen T.I.A., Virtue S., Vidal-Puig A. Obesity as a clinical and public health problem: is there a need for a new definition based on lipotoxicity effects?. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2010, 1801:400-404.
41. Lehnert T., Sonntag D., Konnopka A., Riedel-Heller S., Konig H.H. Economic costs of overweight and obesity. Best Practice & Research Clinical Endocrinology & Metabolism 2013, 27:105-115.
42. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013, 127:e6-e245.
43. Popkin B.M., Adair L.S., Ng S.W. Global nutrition transition and the pandemic of obesity in developing countries. Nutrition Reviews 2012, 70:3-21.
44. World health report 1995, World Health Organization, Geneva, Switzerland.
45. Beaglehold R., Erwin A., Prentece T. World health report 2004, World Health Organization, Geneva, Switzerland.
46. Musgrove P., Creese A., Preker A., Baeza C., Anell A., Prentice T. World health report 2000, World Health Organization, Geneva, Switzerland.
47. Trevino Villarreal D.C., Lopez Guevara V., Ramirez Lopez L.E., Tijerina Saenz A. Relationship of serum cortisol and metabolic syndrome components, dietary intakes and anxiety disorder in children at 8 to 12 years of age with obesity. Nutricion Hospitalaria: Organo Oficial de la Sociedad Espanola de Nutricion Parenteral y Enteral 2012, 27:1562-1568.
48. Leading causes of death. Center for Disease Control and Prevention; September 17, 2012.
49. Pedersen S.D. Metabolic complications of obesity. Best Practice & Research Clinical Endocrinology & Metabolism 2013, 27:179-193.
50. Kuswanto C.N., Sum M.Y., Yang G.L., Nowinski W.L., McIntyre R.S., Sim K. Increased body mass index makes an impact on brain white-matter integrity in adults with remitted first-episode mania. Psychological Medicine 2013, 1-9.
51. Volkow N.D., Wang G.J., Tomasi D., Baler R.D. The addictive dimensionality of obesity. Biological Psychiatry 2013, 73:811-818.
52. Volkow N.D., Wang G.J., Tomasi D., Baler R.D. Obesity and addiction: neurobiological overlaps. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity 2013, 14:2-18.
53. Tomasi D., Volkow N.D. Striatocortical pathway dysfunction in addiction and obesity: differences and similarities. Critical Reviews in Biochemistry and Molecular Biology 2013, 48:1-19.
54. Arkes J. Longitudinal association between marital disruption and child BMI and obesity. Obesity (Silver Spring, MD) 2012, 20:1696-1702.
55. Bornstein S.R., Schuppenies A., Wong M.L., Licinio J. Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions. Molcular Psychiatry 2006, 11:892-902.
56. Murphy D.L., Uhl G.R., Holmes A., Ren-Patterson R., Hall F.S., Sora I., et al. Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders. Genes, Brain and Behavior 2003, 2:350-364.
57. Uceyler N., Schutt M., Palm F., Vogel C., Meier M., Schmitt A., et al. Lack of the serotonin transporter in mice reduces locomotor activity and leads to gender-dependent late onset obesity. International Journal of Obesity (London) 2010, 34:701-711.
58. Koizumi H., Hashimoto K., Iyo M. Dietary restriction changes behaviours in brain-derived neurotrophic factor heterozygous mice: role of serotonergic system. European Journal of Neuroscience 2006, 24:2335-2344.
59. Rios M., Fan G., Fekete C., Kelly J., Bates B., Kuehn R., et al. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Molcular Endocrinology 2001, 15:1748-1757.
60. Ren-Patterson R.F., Cochran L.W., Holmes A., Sherrill S., Huang S.J., Tolliver T., et al. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. Journal of Neuroscience Research 2005, 79:756-771.
61. Wurtman R.J., Wurtman J.J. Brain serotonin, carbohydrate-craving, obesity and depression. Obesity Research 1995, 3(Suppl. 4):477S-480S.
62. Haahr M.E., Rasmussen P.M., Madsen K., Marner L., Ratner C., Gillings N., et al. Obesity is associated with high serotonin 4 receptor availability in the brain reward circuitry. Neuroimage 2012, 61:884-888.
63. Meguid M.M., Fetissov S.O., Varma M., Sato T., Zhang L., Laviano A., et al. Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 2000, 16:843-857.
64. Murphy D.L. Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems. Neuropsychopharmacology 1990, 3:457-471.
65. Naughton M., Mulrooney J.B., Leonard B.E. A review of the role of serotonin receptors in psychiatric disorders. Human Psychopharmacology 2000, 15:397-415.
66. Xu B., Goulding E.H., Zang K., Cepoi D., Cone R.D., Jones K.R., et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nature Neuroscience 2003, 6:736-742.
67. Kernie S.G., Liebl D.J., Parada L.F. BDNF regulates eating behavior and locomotor activity in mice. EMBO Journal 2000, 19:1290-1300.
68. Mattson M.P., Maudsley S., Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends in Neurosciences 2004, 27:589-594.
69. Martinowich K., Lu B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 2008, 33:73-83.
70. Rodriguiz R.M., Wilkins J.J., Creson T.K., Biswas R., Berezniuk I., Fricker A.D., et al. Emergence of anxiety-like behaviours in depressive-like Cpefat/fat mice. International Journal of Neuropsychopharmacology 2013, 16:1623-1634.
71. Wachira S.J., Hughes-Darden C.A., Nicholas H.B., Taylor C.V., Robinson T.J. Neural melanocortin receptors are differentially expressed and regulated by stress in rat hypothalamic-pituitary-adrenal axis. Cell and Molecular Biology (Noisy-le-grand) 2004, 50:703-713.
72. Girardet C., Butler A.A. Neural melanocortin receptors in obesity and related metabolic disorders. Biochimica et Biophysica Acta 2013, 10.1016/j.bbadis.2013.05.004.
73. Xu P., Grueter B.A., Britt J.K., McDaniel L., Huntington P.J., Hodge R., et al. Double deletion of melanocortin 4 receptors and SAPAP3 corrects compulsive behavior and obesity in mice. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:10759-10764.
74. Hahn T.M., Breininger J.F., Baskin D.G., Schwartz M.W. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nature Neuroscience 1998, 1:271-272.
75. Greenman Y., Kuperman Y., Drori Y., Asa S.L., Navon I., Forkosh O., et al. Postnatal ablation of POMC neurons induces an obese phenotype characterized by decreased food intake and enhanced anxiety-like behavior. Molecular Endocrinology 2013, 27:1091-1102.
76. Iemolo A., Blasio A., St Cyr S.A., Jiang F., Rice K.C., Sabino V., et al. CRF-CRF receptor system in the central and basolateral nuclei of the amygdala differentially mediates excessive eating of palatable food. Neuropsychopharmacology 2013, 10.1038/npp.2013.147.
77. Haque Z., Akbar N., Yasmin F., Haleem M.A., Haleem D.J. Inhibition of immobilization stress-induced anorexia, behavioral deficits, and plasma corticosterone secretion by injected leptin in rats. Stress 2013, 16:353-362.
78. Sasaki A., de Vega W.C., St-Cyr S., Pan P., McGowan P.O. Perinatal high fat diet alters glucocorticoid signaling and anxiety behavior in adulthood. Neuroscience 2013, 240:1-12.
79. Cachat J., Stewart A., Grossman L., Gaikwad S., Kadri F., Min Chung K., et al. Measuring behavioral and endocrine responses to novelty stress in adult zebrafish. Nature Protocols 2010, 5:1786-1799.
80. Cachat J., Stewart A., Utterback E., Hart P., Gaikwad S., Wong K., et al. Three-dimensional neurophenotyping of adult zebrafish behavior. PLoS ONE 2011, 6:e17597.
81. MacRae C.A., Peterson R.T. Zebrafish-based small molecule discovery. Chemistry & Biology 2003, 10:901-908.
82. Guo S. Linking genes to brain, behavior and neurological diseases: what can we learn from zebrafish?. Genes, Brain and Behavior 2004, 3:63-74.
83. Lohr H., Hammerschmidt M. Zebrafish in endocrine systems: recent advances and implications for human disease. Annual Review of Physiology 2011, 73:183-211.
84. McGonnell I.M., Fowkes R.C. Fishing for gene function - endocrine modelling in the zebrafish. Journal of Endocrinology 2006, 189:425-439.
85. Alevizaki M., Cimponeriu A., Lekakis J., Papamichael C., Chrousos G.P. High anticipatory stress plasma cortisol levels and sensitivity to glucocorticoids predict severity of coronary artery disease in subjects undergoing coronary angiography. Metabolism: Clinical and Experimental 2007, 56:222-226.
86. Björntorp P. Endocrine abnormalities of obesity. Metabolism: Clinical and Experimental 1995, 44(Suppl. 3):21-23.
87. Song Y., Golling G., Thacker T.L., Cone R.D. Agouti-related protein (AGRP) is conserved and regulated by metabolic state in the zebrafish, Danio rerio. Endocrine 2003, 22:257-265.
88. Chagra S.L., Zavala J.K., Hall M.V., Gosselink K.L. Acute and repeated restraint differentially activate orexigenic pathways in the rat hypothalamus. Regulatory Peptides 2011, 167:70-78.
89. Perry S., Ekker M., Farrell A., Brauner C. Fish Physiology: Zebrafish 2010, Elsvier, Oxford, UK.
90. Ando H., Urano A. Molecular regulation of gonadotropin secretion by gonadotropin-releasing hormone in salmonid fishes. Zoological Science 2005, 22:379-389.
91. Karamizadeh Z., Tabebordbar M., Saki F., Karamifar H., Amirhakimi G. The side effects of gonadotropin releasing hormone analog (diphereline) in treatment of idiopathic central precocious puberty. Acta Medica Iranica 2013, 51:41-46.
92. Lundberg J.M., Martinsson A., Hemsen A., Theodorsson-Norheim E., Svedenhag J., Ekblom B., et al. Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochemical and Biophysical Research Communications 1985, 133:30-36.
93. Matsuda K., Sakashita A., Yokobori E., Azuma M. Neuroendocrine control of feeding behavior and psychomotor activity by neuropeptideY in fish. Neuropeptides 2012, 46:275-283.
94. Stanley B.G., Leibowitz S.F. Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proceedings of the National Academy of Sciences of the United States of America 1985, 82:3940-3943.
95. Kuo L.E., Czarnecka M., Kitlinska J.B., Tilan J.U., Kvetnansky R., Zukowska Z. Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome. Annals of the New York Academy of Sciences 2008, 1148:232-237.
96. Kuo L.E., Kitlinska J.B., Tilan J.U., Li L., Baker S.B., Johnson M.D., et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nature Medicine 2007, 13:803-811.
97. Abe K., Kuo L., Zukowska Z. Neuropeptide Y is a mediator of chronic vascular and metabolic maladaptations to stress and hypernutrition. Experimental Biology and Medicine (Maywood, NJ) 2010, 235:1179-1184.
98. Li L., Najafi A.H., Kitlinska J.B., Neville R., Laredo J., Epstein S.E., et al. Of mice and men: neuropeptide Y and its receptors are associated with atherosclerotic lesion burden and vulnerability. Journal of Cardiovascular Translational Research 2011, 4:351-362.
99. Yokobori E., Azuma M., Nishiguchi R., Kang K.S., Kamijo M., Uchiyama M., et al. Neuropeptide Y stimulates food intake in the zebrafish, Danio rerio. Journal of Neuroendocrinology 2012, 24:766-773.
100. Kaijser L., Pernow J., Berglund B., Lundberg J.M. Neuropeptide Y is released together with noradrenaline from the human heart during exercise and hypoxia. Clinical Physiology (Oxford, England) 1990, 10:179-188.
101. Zukowska-Grojec Z., Vaz A.C. Role of neuropeptide Y (NPY) in cardiovascular responses to stress. Synapse (New York, NY) 1988, 2:293-298.
102. Donoso M.V., Miranda R., Irarrazaval M.J., Huidobro-Toro J.P. Neuropeptide Y is released from human mammary and radial vascular biopsies and is a functional modulator of sympathetic cotransmission. Journal of Vascular Research 2004, 41:387-399.
103. Zukowska-Grojec Z., Konarska M., McCarty R. Differential plasma catecholamine and neuropeptide Y responses to acute stress in rats. Life Sciences 1988, 42:1615-1624.
104. Hirsch D., Zukowska Z. NPY and stress 30 years later: the peripheral view. Cellular and Molecular Neurobiology 2012, 32:645-659.
105. Prokop J.W., Duff R.J., Ball H.C., Copeland D.L., Londraville R.L. Leptin and leptin receptor: analysis of a structure to function relationship in interaction and evolution from humans to fish. Peptides 2012, 38:326-336.
106. Zhou Y., Rui L. Leptin signaling and leptin resistance. Frontiers of Medicine 2013, 7:207-222.
107. Gorissen M., Bernier N.J., Nabuurs S.B., Flik G., Huising M.O. Two divergent leptin paralogues in zebrafish (Danio rerio) that originate early in teleostean evolution. The Journal of Endocrinology 2009, 201:329-339.
108. Volkoff H., Eykelbosh A.J., Peter R.E. Role of leptin in the control of feeding of goldfish Carassius auratus: interactions with cholecystokinin, neuropeptide Y and orexin A, and modulation by fasting. Brain Research 2003, 972:90-109.
109. Ge J.F., Qi C.C., Zhou J.N. Imbalance of leptin pathway and hypothalamus synaptic plasticity markers are associated with stress-induced depression in rats. Behavioural Brain Research 2013, 249:38-43.
110. Ohno K., Sakurai T. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness. Frontiers in Neuroendocrinology 2008, 29:70-87.
111. Inutsuka A., Yamanaka A. The regulation of sleep and wakefulness by the hypothalamic neuropeptide orexin/hypocretin. Nagoya Journal of Medical Science 2013, 75:29-36.
112. Matsuda K., Azuma M., Kang K.S. Orexin system in teleost fish. Vitamins and Hormones 2012, 89:341-361.
113. Yokobori E., Kojima K., Azuma M., Kang K.S., Maejima S., Uchiyama M., et al. Stimulatory effect of intracerebroventricular administration of orexin A on food intake in the zebrafish, Danio rerio. Peptides 2011, 32:1357-1362.
114. Arendt D.H., Ronan P.J., Oliver K.D., Callahan L.B., Summers T.R., Summers C.H. Depressive behavior and activation of the orexin/hypocretin system. Behavioral Neuroscience 2013, 127:86-94.
115. Johnson P.L., Molosh A., Fitz S.D., Truitt W.A., Shekhar A. Orexin, stress, and anxiety/panic states. Progress in Brain Research 2012, 198:133-161.
116. Novak C.M., Jiang X., Wang C., Teske J.A., Kotz C.M., Levine J.A. Caloric restriction and physical activity in zebrafish (Danio rerio). Neuroscience Letters 2005, 383:99-104.
117. Cruz S.A., Tseng Y.C., Kaiya H., Hwang P.P. Ghrelin affects carbohydrate-glycogen metabolism via insulin inhibition and glucagon stimulation in the zebrafish (Danio rerio) brain. Comparative Biochemistry and Physiology. Part A: Molecular and Integrative Physiology 2010, 156:190-200.
118. Kang K.S., Yahashi S., Matsuda K. Central and peripheral effects of ghrelin on energy balance, food intake and lipid metabolism in teleost fish. Peptides 2011, 32:2242-2247.
119. Jönsson E. The role of ghrelin in energy balance regulation in fish. General and Comparative Endocrinology 2013, 187:79-85.
120. Amole N., Unniappan S. Fasting induces preproghrelin mRNA expression in the brain and gut of zebrafish, Danio rerio. General and Comparative Endocrinology 2009, 161:133-137.
121. Mohan H., Unniappan S. Discovery of ghrelin o-acyltransferase. Endocrine Development 2013, 25:16-24.
122. Patterson Z.R., Khazall R., Mackay H., Anisman H., Abizaid A. Central ghrelin signaling mediates the metabolic response of C57BL/6 male mice to chronic social defeat stress. Endocrinology 2013, 154:1080-1091.
123. Spencer S.J., Xu L., Clarke M.A., Lemus M., Reichenbach A., Geenen B., et al. Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress. Biological Psychiatry 2012, 72:457-465.
124. Norton W., Bally-Cuif L. Adult zebrafish as a model organism for behavioural genetics. BMC Neuroscience 2010, 11:90.
125. Norton W.H., Stumpenhorst K., Faus-Kessler T., Folchert A., Rohner N., Harris M.P., et al. Modulation of Fgfr1a signaling in zebrafish reveals a genetic basis for the aggression-boldness syndrome. Journal of Neuroscience 2011, 31:13796-13807.
126. Steenbergen P.J., Richardson M.K., Champagne D.L. The use of the zebrafish model in stress research. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011, 35:1432-1451.
127. Sadler K.C., Amsterdam A., Soroka C., Boyer J., Hopkins N. A genetic screen in zebrafish identifies the mutants vps18, nf2 and foie gras as models of liver disease. Development (Cambridge, England) 2005, 132:3561-3572.
128. Yin J.W., Liang Y., Park J.Y., Chen D., Yao X., Xiao Q., et al. Mediator MED23 plays opposing roles in directing smooth muscle cell and adipocyte differentiation. Genes & Development 2012, 26:2192-2205.
129. Wang W., Huang L., Huang Y., Yin J.W., Berk A.J., Friedman J.M., et al. Mediator MED23 links insulin signaling to the adipogenesis transcription cascade. Developmental Cell 2009, 16:764-771.
130. McMenamin S.K., Minchin J.E., Gordon T.N., Rawls J.F., Parichy D.M. Dwarfism and increased adiposity in the gh1 mutant zebrafish vizzini. Endocrinology 2013, 154:1476-1487.
131. Berryman D.E., List E.O., Coschigano K.T., Behar K., Kim J.K., Kopchick J.J. Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Hormone & IGF Research 2004, 14:309-318.
132. Morris P., Hopwood M., Maguire K., Norman T., Schweitzer I. Blunted growth hormone response to clonidine in post-traumatic stress disorder. Psychoneuroendocrinology 2004, 29:269-278.
133. Twigg S.R., Lloyd D., Jenkins D., Elcioglu N.E., Cooper C.D., Al-Sannaa N., et al. Mutations in multidomain protein MEGF8 identify a Carpenter syndrome subtype associated with defective lateralization. American Journal of Human Genetics 2012, 91:897-905.
134. Chalasani N., Deeg M.A., Crabb D.W. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. The American Journal of Gastroenterology 2004, 99:1497-1502.
135. Schlegel A. Studying non-alcoholic fatty liver disease with zebrafish: a confluence of optics, genetics, and physiology. Cellular and Molecular Life Sciences: CMLS 2012, 69:3953-3961.
136. Thakur P.C., Stuckenholz C., Rivera M.R., Davison J.M., Yao J.K., Amsterdam A., et al. Lack of de novo phosphatidylinositol synthesis leads to endoplasmic reticulum stress and hepatic steatosis in cdipt-deficient zebrafish. Hepatology (Baltimore, MD) 2011, 54:452-462.
137. Matthews R.P., Lorent K., Manoral-Mobias R., Huang Y., Gong W., Murray I.V., et al. TNFalpha-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish S-adenosylhomocysteine hydrolase. Development (Cambridge, England) 2009, 136:865-875.
138. Hugo S.E., Cruz-Garcia L., Karanth S., Anderson R.M., Stainier D.Y., Schlegel A. A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting. Genes & Development 2012, 26:282-293.
139. Ragvin A., Moro E., Fredman D., Navratilova P., Drivenes O., Engstrom P.G., et al. Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:775-780.
140. Golzio C., Willer J., Talkowski M.E., Oh E.C., Taniguchi Y., Jacquemont S., et al. KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant. Nature 2012, 485:365-367.
141. Miller D.R., Nasir R., Sobeih M.M., Shen Y., Wu B.-L., Hanson E. 16p11.2 Microdeletion. GeneReviews (tm) [Internet] 2013, Seattle, Seattle (WA): University of Washington. http://www.ncbi.nlm.nih.gov/books/NBK11167/.
142. Walters R.G., Jacquemont S., Valsesia A., de Smith A.J., Martinet D., Andersson J., et al. A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature 2010, 463:671-675.
143. Blaut M., Klaus S. Intestinal microbiota and obesity. Handbook of Experimental Pharmacology 2012, 25:1-73.
144. Kallus S.J., Brandt L.J. The intestinal microbiota and obesity. Journal of Clinical Gastroenterology 2012, 46:16-24.
145. Tsai F., Coyle W.J. The microbiome and obesity: is obesity linked to our gut flora. Current Gastroenterology Reports 2009, 11:307-313.
146. Cryan J.F., Dinan T.G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience 2012, 13:701-712.
147. Rawls J.F., Mahowald M.A., Ley R.E., Gordon J.I. Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell 2006, 127:423-433.
148. Wang Z., Du J., Lam S.H., Mathavan S., Matsudaira P., Gong Z. Morphological and molecular evidence for functional organization along the rostrocaudal axis of the adult zebrafish intestine. BMC Genomics 2010, 11:392.
149. Wang T., Hung C.C., Randall D.J. The comparative physiology of food deprivation: from feast to famine. Annual Review of Physiology 2006, 68:223-251.
150. Oka T., Nishimura Y., Zang L., Hirano M., Shimada Y., Wang Z., et al. Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiology 2010, 10:21.
151. Tainaka T., Shimada Y., Kuroyanagi J., Zang L., Oka T., Nishimura Y., et al. Transcriptome analysis of anti-fatty liver action by Campari tomato using a zebrafish diet-induced obesity model. Nutrition & Metabolism 2011, 8:88.
152. Flynn E.J., Trent C.M., Rawls J.F. Ontogeny and nutritional control of adipogenesis in zebrafish (Danio rerio). Journal of Lipid Research 2009, 50:1641-1652.
153. Dallman M.F., Pecoraro N., Akana S.F., La Fleur S.E., Gomez F., Houshyar H., et al. Chronic stress and obesity: a new view of "comfort food". Proceedings of the National Academy of Sciences of the United States of America 2003, 100:11696-11701.
154. Scherer P.E., Williams S., Fogliano M., Baldini G., Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. The Journal of Biological Chemistry 1995, 270:26746-26749.
155. Yamauchi T., Hara K., Kubota N., Terauchi Y., Tobe K., Froguel P., et al. Dual roles of adiponectin/Acrp30 in vivo as an anti-diabetic and anti-atherogenic adipokine. Current Drug Targets Immune, Endocrine and Metabolic Disorders 2003, 3:243-254.
156. Nishio S., Gibert Y., Bernard L., Brunet F., Triqueneaux G., Laudet V. Adiponectin and adiponectin receptor genes are coexpressed during zebrafish embryogenesis and regulated by food deprivation. Developmental Dynamics: An Official Publication of the American Association of Anatomists 2008, 237:1682-1690.
157. Krolow R., Noschang C., Arcego D.M., Huffell A.P., Marcolin M.L., Benitz A.N., et al. Sex-specific effects of isolation stress and consumption of palatable diet during the prepubertal period on metabolic parameters. Metabolism: Clinical and Experimental 2013, 10.1016/j.metabol.2013.04.009.
158. Park J.H., Choi Y.J., Kim Y.W., Kim S.P., Cho H.C., Ahn S., et al. Green tea extract with polyethylene glycol-3350 reduces body weight and improves glucose tolerance in db/db and high-fat diet mice. Naunyn-Schmiedeberg's Archives of Pharmacology 2013, 386(8):733-745.
159. Wein S., Schrader E., Rimbach G., Wolffram S. Oral green tea catechins transiently lower plasma glucose concentrations in female db/db mice. Journal of Medicinal Food 2013, 16:312-317.
160. Rains T.M., Agarwal S., Maki K.C. Antiobesity effects of green tea catechins: a mechanistic review. Journal of Nutritional Biochemistry 2011, 22:1-7.
161. Wang H., Wen Y., Du Y., Yan X., Guo H., Rycroft J.A., et al. Effects of catechin enriched green tea on body composition. Obesity (Silver Spring) 2010, 18:773-779.
162. Hasumura T., Shimada Y., Kuroyanagi J., Nishimura Y., Meguro S., Takema Y., et al. Green tea extract suppresses adiposity and affects the expression of lipid metabolism genes in diet-induced obese zebrafish. Nutrition & Metabolism 2012, 9:73.
163. Ali M., Nicieza A., Wootton R.J. Compensatory growth in fishes: a response to growth depression. Fish and Fisheries 2003, 4:147-190.
164. Koven W., Schulte P. The effect of fasting and refeeding on mRNA expression of PepT1 and gastrointestinal hormones regulating digestion and food intake in zebrafish (Danio rerio). Fish Physiology and Biochemistry 2012, 38:1565-1575.
165. Shimada Y., Hirano M., Nishimura Y., Tanaka T. A high-throughput fluorescence-based assay system for appetite-regulating gene and drug screening. PLoS ONE 2012, 7:e52549.
166. Papasani M.R., Robison B.D., Hardy R.W., Hill R.A. Early developmental expression of two insulins in zebrafish (Danio rerio). Physiological Genomics 2006, 27:79-85.
167. Maximino C., de Brito T.M., Colmanetti R., Pontes A.A., de Castro H.M., de Lacerda R.I., et al. Parametric analyses of anxiety in zebrafish scototaxis. Behavioural Brain Research 2010, 210:1-7.
168. Chu C.Y., Chen C.F., Rajendran R.S., Shen C.N., Chen T.H., Yen C.C., et al. Overexpression of Akt1 enhances adipogenesis and leads to lipoma formation in zebrafish. PLoS ONE 2012, 7:e36474.
169. Imrie D., Sadler K.C. White adipose tissue development in zebrafish is regulated by both developmental time and fish size. Developmental Dynamics 2010, 239:3013-3023.
170. Misimi E., Erikson U., Digre H., Skavhaug A., Mathiassen J.R. Computer vision-based evaluation of pre- and postrigor changes in size and shape of Atlantic cod (Gadus morhua) and Atlantic salmon (Salmo salar) fillets during rigor mortis and ice storage: effects of perimortem handling stress. Journal of Food Science 2008, 73:E57-E68.
171. ElMasry G., Wold J.P. High-speed assessment of fat and water content distribution in fish fillets using online imaging spectroscopy. Journal of Agricultural and Food Chemistry 2008, 56:7672-7677.
172. Chen Y., Qian L. Association between lifetime stress and obesity in Canadians. Preventive Medicine 2012, 55:464-467.
173. Rutters F., Nieuwenhuizen A.G., Lemmens S.G., Born J.M., Westerterp-Plantenga M.S. Acute stress-related changes in eating in the absence of hunger. Obesity (Silver Spring, MD) 2009, 17:72-77.
174. Ghalami J., Zardooz H., Rostamkhani F., Farrokhi B., Hedayati M. Glucose-stimulated insulin secretion: effects of high-fat diet and acute stress. Journal of Endocrinological Investigation 2013.
175. Kaiser N., Cerasi E., Leibowitz G. Diet-induced diabetes in the sand rat (Psammomys obesus). Methods in Molecular Biology (Clifton, NJ) 2012, 933:89-102.
176. Nguyen M., Yang E., Li A., Li L., Zukowska Z. Stress, obesity and neuropeptide Y - can zebrafish model what happens in mice and humans?. Midwest regional zebrafish conference 2011, 35.
177. Green J., Collins C., Kyzar E.J., Pham M., Roth A., Gaikwad S., et al. Automated high-throughput neurophenotyping of zebrafish social behavior. Journal of Neuroscience Methods 2012, 210:266-271.
178. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities. Obesity Reviews 2001, 2:73-86.
179. Rosmond R., Dallman M.F., Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. Journal of Clinical Endocrinology and Metabolism 1998, 83:1853-1859.
180. Angotzi A.R., Stefansson S.O., Nilsen T.O., Rathore R.M., Ronnestad I. Molecular cloning and genomic characterization of novel Leptin-like genes in salmonids provide new insight into the evolution of the Leptin gene family. General and Comparative Endocrinology 2013, 187:48-59.
181. Moen A.G., Finn R.N. Short-term, but not long-term feed restriction causes differential expression of leptins in Atlantic salmon. General and Comparative Endocrinology 2013, 183:83-88.
182. Murashita K., Jordal A.E., Nilsen T.O., Stefansson S.O., Kurokawa T., Bjornsson B.T., et al. Leptin reduces Atlantic salmon growth through the central pro-opiomelanocortin pathway. Comparative Biochemistry and Physiology, Part A: Molecular and Integrative Physiology 2011, 158:79-86.
183. Tinoco A.B., Nisembaum L.G., Isorna E., Delgado M.J., de Pedro N. Leptins and leptin receptor expression in the goldfish (Carassius auratus). Regulation by food intake and fasting/overfeeding conditions. Peptides 2012, 34:329-335.
184. Vivas Y., Azpeleta C., Feliciano A., Velarde E., Isorna E., Delgado M.J., et al. Time-dependent effects of leptin on food intake and locomotor activity in goldfish. Peptides 2011, 32:989-995.
185. de Pedro N., Martinez-Alvarez R., Delgado M.J. Acute and chronic leptin reduces food intake and body weight in goldfish (Carassius auratus). The Journal of Endocrinology 2006, 188:513-520.
186. Aguilar A.J., Conde-Sieira M., Polakof S., Míguez J.M., Soengas J.L. Central leptin treatment modulates brain glucosensing function and peripheral energy metabolism of rainbow trout. Peptides 2010, 31:1044-1054.
187. Kling P., Jönsson E., Nilsen T.O., Einarsdottir I.E., Rønnestad I., Stefansson S.O., et al. The role of growth hormone in growth, lipid homeostasis, energy utilization and partitioning in rainbow trout: interactions with leptin, ghrelin and insulin-like growth factor I. General and Comparative Endocrinology 2012, 175:153-162.
188. Lu J., Peatman E., Tang H., Lewis J., Liu Z. Profiling of gene duplication patterns of sequenced teleost genomes: evidence for rapid lineage-specific genome expansion mediated by recent tandem duplications. BMC Genomics 2012, 13:246.
189. Semon M., Wolfe K.H. Rearrangement rate following the whole-genome duplication in teleosts. Molecular Biology and Evolution 2007, 24:860-867.
190. Moghadam H.K., Ferguson M.M., Danzmann R.G. Whole genome duplication: challenges and considerations associated with sequence orthology assignment in Salmoninae. Journal of Fish Biology 2011, 79:561-574.
191. Alsop D., Vijayan M. The zebrafish stress axis: molecular fallout from the teleost-specific genome duplication event. General and Comparative Endocrinology 2009, 161:62-66.
192. Piccinetti C.C., Migliarini B., Olivotto I., Coletti G., Amici A., Carnevali O. Appetite regulation: the central role of melatonin in Danio rerio. Hormones and Behavior 2010, 58:780-785.
193. Li X., He J., Hu W., Yin Z. The essential role of endogenous ghrelin in growth hormone expression during zebrafish adenohypophysis development. Endocrinology 2009, 150:2767-2774.
194. Gonzalez-Nunez V., Gonzalez-Sarmiento R., Rodriguez R.E. Identification of two proopiomelanocortin genes in zebrafish (Danio rerio). Brain Research Molecular Brain Research 2003, 120:1-8.
195. Li Y., Li G., Wang H., Du J., Yan J. Analysis of a gene regulatory cascade mediating circadian rhythm in zebrafish. PLoS Computational Biology 2013, 9:e1002940.
196. Tanida M., Hayata A., Shintani N., Yamamoto N., Kurata Y., Shibamoto T., et al. Central PACAP mediates the sympathetic effects of leptin in a tissue-specific manner. Neuroscience 2013, 238:297-304.
197. Dore R., Iemolo A., Smith K.L., Wang X., Cottone P., Sabino V. CRF mediates the anxiogenic and anti-rewarding, but not the anorectic effects of PACAP. Neuropsychopharmacology 2013.
198. Hattori S., Takao K., Tanda K., Toyama K., Shintani N., Baba A., et al. Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout mice. Frontiers in Behavioral Neuroscience 2012, 6:1-18.
199. Sakurai Y., Inoue H., Shintani N., Arimori A., Hamagami K., Hayata-Takano A., et al. Compensatory recovery of blood glucose levels in KKA(y) mice fed a high-fat diet: insulin-sparing effects of PACAP overexpression in beta cells. Journal of Molecular Neuroscience 2012, 48:647-653.
200. Gaszner B., Kormos V., Kozicz T., Hashimoto H., Reglodi D., Helyes Z. The behavioral phenotype of pituitary adenylate-cyclase activating polypeptide-deficient mice in anxiety and depression tests is accompanied by blunted c-Fos expression in the bed nucleus of the stria terminalis, central projecting Edinger-Westphal nucleus, ventral lateral septum, and dorsal raphe nucleus. Neuroscience 2012, 202:283-299.
201. Sherwood N.M., Adams B.A., Isaac E.R., Wu S., Fradinger E.A. Knocked down and out: PACAP in development, reproduction and feeding. Peptides 2007, 28:1680-1687.
202. Wei Y., Martin S.C., Heinrich G., Mojsov S. Cloning and functional characterization of PACAP-specific receptors in zebrafish. Annals of the New York Academy of Sciences 1998, 865:45-48.
203. Mathieu M., Ciarlo M., Trucco N., Griffero F., Damonte G., Salis A., et al. Pituitary adenylate cyclase-activating polypeptide in the brain, spinal cord and sensory organs of the zebrafish, Danio rerio, during development. Brain Research, Developmental Brain Research 2004, 151:169-185.
204. Matsuda K., Maruyama K., Miura T., Uchiyama M., Shioda S. Anorexigenic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: feeding-induced changes in the expression of mRNAs for PACAP and its receptors in the brain, and locomotor response to central injection. Neuroscience Letters 2005, 386:9-13.
205. Matsuda K., Maruyama K., Nakamachi T., Miura T., Uchiyama M., Shioda S. Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus. Peptides 2005, 26:1611-1616.
206. Maruyama K., Miura T., Uchiyama M., Shioda S., Matsuda K. Relationship between anorexigenic action of pituitary adenylate cyclase-activating polypeptide (PACAP) and that of corticotropin-releasing hormone (CRH) in the goldfish, Carassius auratus. Peptides 2006, 27:1820-1826.
207. Pacher P., Kunos G. Modulating the endocannabinoid system in human health and disease--successes and failures. FEBS Journal 2013, 280:1918-1943.
208. Chen G., Pang Z. Endocannabinoids and obesity. Vitamins and Hormones 2013, 91:325-368.
209. Litvin Y., Phan A., Hill M.N., Pfaff D.W., McEwen B.S. CB1 receptor signaling regulates social anxiety and memory. Genes, Brain and Behavior 2013, 12:479-489.
210. Naughton S.S., Mathai M.L., Hryciw D.H., McAinch A.J. Fatty Acid modulation of the endocannabinoid system and the effect on food intake and metabolism. International Journal of Endocrinology 2013, 2013:361895.
211. Le Foll B., Trigo J.M., Sharkey K.A., Le Strat Y. Cannabis and Delta9-tetrahydrocannabinol (THC) for weight loss?. Medical Hypotheses 2013, 80:564-567.
212. Wong A., Gunasekaran N., Hancock D.P., Denyer G.S., Meng L., Radford J.L., et al. The major plant-derived cannabinoid Delta(9)-tetrahydrocannabinol promotes hypertrophy and macrophage infiltration in adipose tissue. Hormone and Metabolic Research 2012, 44:105-113.
213. O'Keefe L., Simcocks A., Hryciw D., Mathai M., McAinch A. The Cannabinoid Receptor 1 and its role in influencing peripheral metabolism. Diabetes, Obesity and Metabolism 2013.
214. Almeida-Santos A.F., Gobira P.H., Rosa L.C., Guimaraes F.S., Moreira F.A., Aguiar D.C. Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray. Behavioural Brain Research 2013, 252:10-17.
215. Gobira P.H., Aguiar D.C., Moreira F.A. Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activities in the elevated T-maze. Pharmacology Biochemistry and Behavior 2013, 110C:33-39.
216. Franklin J.M., Mathew M., Carrasco G.A. Cannabinoid-induced upregulation of serotonin 2A receptors in the hypothalamic paraventricular nucleus and anxiety-like behaviors in rats. Neuroscience Letters 2013.
217. Nishio S., Gibert Y., Berekelya L., Bernard L., Brunet F., Guillot E., et al. Fasting induces CART down-regulation in the zebrafish nervous system in a cannabinoid receptor 1-dependent manner. Molecular Endocrinology 2012, 26(8):1316-1326.
218. Cottone E., Pomatto V., Cerri F., Campantico E., Mackie K., Delpero M., et al. Cannabinoid receptors are widely expressed in goldfish: molecular cloning of a CB2-like receptor and evaluation of CB1 and CB2 mRNA expression profiles in different organs. Fish Physiology and Biochemistry 2013.
219. Pai W.Y., Hsu C.C., Lai C.Y., Chang T.Z., Tsai Y.L., Her G.M. Cannabinoid receptor 1 promotes hepatic lipid accumulation and lipotoxicity through the induction of SREBP-1c expression in zebrafish. Transgenic Research 2013, 22(4):823-838.
220. Lam C.S., Rastegar S., Strahle U. Distribution of cannabinoid receptor 1 in the CNS of zebrafish. Neuroscience 2006, 138(1):83-95.
221. Rodriguez-Martin I., de Velasco E.M., Rodriguez R.E. Characterization of cannabinoid-binding sites in zebrafish brain. Neuroscience Letters 2007, 413:249-254.
222. Rodriguez-Martin I., Herrero-Turrion M.J., Marron Fdez de Velasco E., Gonzalez-Sarmiento R., Rodriguez R.E. Characterization of two duplicate zebrafish Cb2-like cannabinoid receptors. Gene 2007, 389:36-44.
223. Migliarini B., Carnevali O. Anandamide modulates growth and lipid metabolism in the zebrafish Danio rerio. Molecular and Cellular Endocrinology 2008, 286:S12-S16.
224. Braida D., Limonta V., Pegorini S., Zani A., Guerini-Rocco C., Gori E., et al. Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement. Psychopharmacology 2007, 190:441-448.
225. Stewart A., Kalueff A. Acute effects of heroin and marijuana in adult zebrafish. 20th Insternational ISBS Stress and Behavior Conference 2013, 19-20.
226. Akhtar M.T., Ali S., Verpoorte R., Richardson M.K. Behavioral effects of cannabinoids on zebrafish larvae. 2012 International Congress on Natural Products Research 2012, p.pPD123. M. O'Neil-Johnson (Ed.).
227. Stewart A., Gaikwad S., Hart P., Kyzar E., Roth A., Kalueff A. Experimental models for anxiolytic drug discovery in the era of omes and omics. Expert Opinion on Drug Discovery 2011, 6.
228. Abu-Asab M.S., Chaouchi M., Alesci S., Galli S., Laassri M., Cheema A.K., et al. Biomarkers in the age of omics: time for a systems biology approach. OMICS 2011, 15:105-112.
229. Abu-Issa R., Kirby M.L. Take heart in the age of "omics". Circulation Research 2004, 95:335-336.
230. Alvarez-Llamas G., Szalowska E., de Vries M.P., Weening D., Landman K., Hoek A., et al. Characterization of the human visceral adipose tissue secretome. Molecular and Cellular Proteomics 2007, 6:589-600.
231. Zhou H., Xiao Y., Li R., Hong S., Li S., Wang L., et al. Quantitative analysis of secretome from adipocytes regulated by insulin. Acta Biochimica et Biophysica Sinica (Shanghai) 2009, 41:910-921.
232. Morrison R.S., Kinoshita Y., Johnson M.D., Uo T., Ho J.T., McBee J.K., et al. Proteomic analysis in the neurosciences. Molecular and Cellular Proteomics 2002, 1:553-560.
233. Clelland J.D., Sacco R., Persico A., Garbett K., Mirnics K. Genome-wide expression studies in autism-spectrum disorders: moving from neurodevelopment to neuroimmunology. Genomics, proteomics, and the nervous system 2011, 469-487. Springer, New York.
234. Plazas-Mayorca M.D., Vrana K.E. Proteomic investigation of epigenetics in neuropsychiatric disorders: a missing link between genetics and behavior. Journal of Proteome Research 2011, 10:58-65.
235. Thorleifsson G., Walters G.B., Gudbjartsson D.F., Steinthorsdottir V., Sulem P., Helgadottir A., et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nature Genetics 2009, 41:18-24.
236. Bauer F., Elbers C.C., Adan R.A., Loos R.J., Onland-Moret N.C., Grobbee D.E., et al. Obesity genes identified in genome-wide association studies are associated with adiposity measures and potentially with nutrient-specific food preference. American Journal of Clinical Nutrition 2009, 90:951-959.
237. Sequeira A., Turecki G. Genome wide gene expression studies in mood disorders. OMICS 2006, 10:444-454.
238. Phan J.H., Quo C.F., Wang M.D. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics. Progress in Brain Research 2006, 158:83-108.
239. Wong R.Y., Oxendine S.E., Godwin J. Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatment. BMC Genomics 2013, 14:348.
240. Mirnics K., Middleton F.A., Lewis D.A., Levitt P. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends in Neurosciences 2001, 24:479-486.
241. Pongrac J., Middleton F.A., Lewis D.A., Levitt P., Mirnics K. Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders. Neurochemical Research 2002, 27:1049-1063.
242. Kim S., Webster M.J. Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Molecular Psychiatry 2010, 15:326-336.
243. Xie B., Waters M.J., Schirra H.J. Investigating potential mechanisms of obesity by metabolomics. Journal of Biomedicine and Biotechnology 2012, 2012:805683.
244. Kussmann M., Raymond F., Affolter M. OMICS-driven biomarker discovery in nutrition and health. Journal of Biotechnology 2006, 124:758-787.
245. Li H., Xie Z., Lin J., Song H., Wang Q., Wang K., et al. Transcriptomic and metabonomic profiling of obesity-prone and obesity-resistant rats under high fat diet. Journal of Proteome Research 2008, 7:4775-4783.
246. Soanes K.H., Achenbach J.C., Burton I.W., Hui J.P., Penny S.L., Karakach T.K. Molecular characterization of zebrafish embryogenesis via DNA microarrays and multiplatform time course metabolomics studies. Journal of Proteome Research 2011, 10:5102-5117.
247. Raterink R.-J., Kloet F., Li J., Wattel N., Schaaf M., Spaink H., et al. Rapid metabolic screening of early zebrafish embryogenesis based on direct infusion-nanoESI-FTMS. Metabolomics 2013, 1-10.
248. Ashrafian H., Harling L., Darzi A., Athanasiou T. Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions?. Metabolic Brain Disease 2013.
249. Lee E.B. Obesity, leptin, and Alzheimer's disease. Annals of the New York Academy of Sciences 2011, 1243:15-29.
250. Diwan A., Aziz K., Rishi P., Kavita K., Firoz C., Kamal M. Spectrum from obesity to neurodegenerative disorder. American Journal of Neuroprotection and Neuroregeneration 2012, 4:31-39.
251. Sriram K., Benkovic S.A., Miller D.B., O'Callaghan J.P. Obesity exacerbates chemically induced neurodegeneration. Neuroscience 2002, 115:1335-1346.
252. Leboucher A., Laurent C., Fernandez-Gomez F.J., Burnouf S., Troquier L., Eddarkaoui S., et al. Detrimental effects of diet-induced obesity on tau pathology are independent of insulin resistance in tau transgenic mice. Diabetes 2013, 62:1681-1688.
253. Susaki E., Nakayama K.I. An animal model manifesting neurodegeneration and obesity. Aging (Albany NY) 2010, 2:453-456.
254. Kishi S., Slack B.E., Uchiyama J., Zhdanova I.V. Zebrafish as a genetic model in biological and behavioral gerontology: where development meets aging in vertebrates - a mini-review. Gerontology 2009, 55:430-441.
255. Yu L., Tucci V., Kishi S., Zhdanova I.V. Cognitive aging in zebrafish. PLoS ONE 2006, 1:e14.
256. Mahmood F., Fu S., Cooke J., Wilson S.W., Cooper J.D., Russell C. A zebrafish model of CLN2 disease is deficient in tripeptidyl peptidase 1 and displays progressive neurodegeneration accompanied by a reduction in proliferation. Brain 2013, 136:1488-1507.
257. Noble S., Ismail A., Godoy R., Xi Y., Ekker M. Zebrafish Parla- and Parlb-deficiency affects dopaminergic neuron patterning and embryonic survival. Journal of Neurochemistry 2012, 122:196-207.
258. Doherty G. Obesity and the ageing brain: could leptin play a role in neurodegeneration. Current Gerontology and Geriatrics Research 2011, 2011:1-8.
259. Armitage J.A., Poston L., Taylor P.D. Developmental origins of obesity and the metabolic syndrome: the role of maternal obesity. Frontiers of Hormone Research 2008, 36:73-84.
260. Taylor P.D., Poston L. Developmental programming of obesity in mammals. Experimental Physiology 2007, 92:287-298.
261. Li M., Sloboda D.M., Vickers M.H. Maternal obesity and developmental programming of metabolic disorders in offspring: evidence from animal models. Journal of Diabetes Research 2011, 2011:592408.
262. Langley-Evans S.C., Bellinger L., McMullen S. Animal models of programming: early life influences on appetite and feeding behaviour. Maternal & Child Nutrition 2005, 1:142-148.
263. Chakraborty C., Hsu C.H., Wen Z.H., Lin C.S., Agoramoorthy G. Zebrafish: a complete animal model for in vivo drug discovery and development. Current Drug Metabolism 2009, 10:116-124.
264. Key B., Devine C.A. Zebrafish as an experimental model: strategies for developmental and molecular neurobiology studies. Methods in Cell Science 2003, 25:1-6.
265. Hayes M.R., Bradley L., Grill H.J. Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling. Endocrinology 2009, 150:2654-2659.
266. Best J.D., Alderton W.K. Zebrafish An in vivo model for the study of neurological diseases. Journal of Neuropsychiatric Disease and Treatment 2008, 4:567-576.
267. Gerlai R. High-throughput behavioral screens: the first step towards finding genes involved in vertebrate brain function using zebrafish. Molecules 2010, 15:2609-2622.
268. Rihel J., Schier A.F. Behavioral screening for neuroactive drugs in zebrafish. Developmental Neurobiology 2011.
269. Avramopoulos D. Genetics of psychiatric disorders methods: molecular approaches. Psychiatric Clinics of North America 2010, 33(1):1-13.
270. Cannon T.D., Keller M.C. Endophenotypes in the genetic analyses of mental disorders. Annual Review of Clinical Psychology 2006, 2:267-290.
271. Lepine J.P. The epidemiology of anxiety disorders: prevalence and societal costs. Journal of Clinical Psychiatry 2002, 63(Suppl. 14):4-8.
272. Twenge J.M. The age of anxiety? Birth cohort change in anxiety and neuroticism, 1952-1993. Journal of Personality and Social Psychology 2000, 79:1007-1021.
273. McKay R.M., McKay J.P., Avery L., Graff J.M. C. elegans: a model for exploring the genetics of fat storage. Developmental Cell 2003, 4:131-142.
274. Skorupa D.A., Dervisefendic A., Zwiener J., Pletcher S.D. Dietary composition specifies consumption, obesity, and lifespan in Drosophila melanogaster. Aging Cell 2008, 7:478-490.
275. Srinivasan S., Sadegh L., Elle I.C., Christensen A.G., Faergeman N.J., Ashrafi K. Serotonin regulates C. elegans fat and feeding through independent molecular mechanisms. Cell Metabolism 2008, 7:533-544.
276. Horvitz H.R., Chalfie M., Trent C., Sulston J.E., Evans P.D. Serotonin and octopamine in the nematode Caenorhabditis elegans. Science (New York, NY) 1982, 216:1012-1014.
277. Kim H.M., Do C.H., Lee D.H. Characterization of taurine as anti-obesity agent in C. elegans. Journal of Biomedical Science 2010, 17(Suppl. 1):S33.
278. Subramanian M., Metya S.K., Sadaf S., Kumar S., Schwudke D., Hasan G. Altered lipid homeostasis in Drosophila InsP3 receptor mutants leads to obesity and hyperphagia. Disease Models & Mechanisms 2013, 6:734-744.
279. Heinrichsen E.T., Haddad G.G. Role of high-fat diet in stress response of Drosophila. PLoS ONE 2012, 7:e42587.
280. Nakamachi T., Matsuda K., Maruyama K., Miura T., Uchiyama M., Funahashi H., et al. Regulation by orexin of feeding behaviour and locomotor activity in the goldfish. Journal of Neuroendocrinology 2006, 18:290-297.
281. Podrini C., Cambridge E.L., Lelliott C.J., Carragher D.M., Estabel J., Gerdin A.K., et al. High-fat feeding rapidly induces obesity and lipid derangements in C57BL/6N mice. Mammalian Genome: Official Journal of the International Mammalian Genome Society; 2013.
282. Ruohonen S.T., Pesonen U., Savontaus E. Neuropeptide Y in the noradrenergic neurons induces the development of cardiometabolic diseases in a transgenic mouse model. Indian Journal of Endocrinology and Metabolism 2012, 16:569-576.
283. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
284. Lembertas A.V., Perusse L., Chagnon Y.C., Fisler J.S., Warden C.H., Purcell-Huynh D.A., et al. Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. Journal of Clinical Investigation 1997, 100:1240-1247.
285. Zucker L., Zucker T.F. Fatty, a new mutation in the rat. Journal of Heredity 1961, 52:275-278.
286. Kemmochi Y., Fukui K., Maki M., Kimura S., Ishii Y., Sasase T., et al. Metabolic disorders and diabetic complications in spontaneously diabetic torii lepr (fa) rat: a new obese type 2 diabetic model. Journal of Diabetes Research 2013, 2013:948257.
287. Takemori K., Kimura T., Shirasaka N., Inoue T., Masuno K., Ito H. Food restriction improves glucose and lipid metabolism through Sirt1 expression: a study using a new rat model with obesity and severe hypertension. Life Sciences 2011, 88:1088-1094.
288. Ramsey J.J., Kemnitz J.W., Newton W., Hagopian K., Patterson T.A., Swick A.G. Food intake in rhesus monkeys following central administration of orexins. Regulatory Peptides 2005, 124:209-214.
289. Setler P.E., Smith G.P. Increased food intake elicited by adrenergic stimulation of the diencephalon in rhesus monkeys. Brain Research 1974, 65:459-473.
290. Shively C.A., Register T.C., Clarkson T.B. Social stress, visceral obesity, and coronary artery atherosclerosis: product of a primate adaptation. American Journal of Primatology 2009, 71:742-751.
291. Mathur R., Manchanda S.K., Oomura Y., Nayar U. 2-Buten 4 olide affects feeding behavior of rhesus monkey. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1996, 20:167-176.
292. Lyche J.L., Nourizadeh-Lillabadi R., Almaas C., Stavik B., Berg V., Skare J.U., et al. Natural mixtures of persistent organic pollutants (POP) increase weight gain, advance puberty, and induce changes in gene expression associated with steroid hormones and obesity in female zebrafish. Journal of Toxicology and Environmental Health, Part A 2010, 73:1032-1057.
293. Lyche J.L., Nourizadeh-Lillabadi R., Karlsson C., Stavik B., Berg V., Skåre J.U., et al. Natural mixtures of POPs affected body weight gain and induced transcription of genes involved in weight regulation and insulin signaling. Aquatic Toxicology 2011, 102:197-204.
294. Nishiguchi R., Azuma M., Yokobori E., Uchiyama M., Matsuda K. Gonadotropin-releasing hormone 2 suppresses food intake in the zebrafish, Danio rerio. Frontiers in Endocrinology (Lausanne) 2012, 3:122.
295. Diekmann H., Anichtchik O., Fleming A., Futter M., Goldsmith P., Roach A., et al. Decreased BDNF levels are a major contributor to the embryonic phenotype of huntingtin knockdown zebrafish. Journal of Neuroscience 2009, 29:1343-1349.
296. Matsuda K., Hagiwara Y., Shibata H., Wada K. Ovine corticotropin-releasing hormone (CRH) exerts an anxiogenic-like action in the goldfish, Carassius auratus. General and Comparative Endocrinology 2013, 0.
297. Matsuda K., Wada K., Azuma M., Leprince J., Tonon M.C., Sakashita A., et al. The octadecaneuropeptide exerts an anxiogenic-like action in goldfish. Neuroscience 2011, 181:100-108.
298. Matsuda K., Maruyama K., Nakamachi T., Miura T., Shioda S. Effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on food intake and locomotor activity in the goldfish, Carassius auratus. Annals of the New York Academy of Sciences 2006, 1070:417-421.